Drugs Made In America Acquisition Corp. Rights
DMAAR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.83M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.83 Million |
|---|---|
| Enterprise Value | $2.76 Million |
| Earnings per Share | $0.19 |
| Beta | 3.92 |
| Outstanding Shares | 20,095,314 |
Return
| Return on Equity | 4.42% |
|---|---|
| Return on Assets | 4.15% |
| Return on Invested Capital | -1.83% |
Valuation & Multiples
| P/E Ratio | 55.48 |
|---|---|
| PEG | -226.04 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Drugs Made In America Acquisition Corp. Ordinary Shares
2 employees
CEO: Roger Bendelac
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with...